Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02844504
Other study ID # R-849-14
Secondary ID 5R01CA189665-02
Status Completed
Phase N/A
First received
Last updated
Start date May 2016
Est. completion date September 2020

Study information

Verified date October 2020
Source Kessler Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Breast cancer patients often suffer from long-term physical symptoms of weakness. In this study, investigators propose to compare how two different low intensity physical exercise training programs can improve handgrip strength for breast cancer patients with symptoms of weakness. Using brain imaging, the study will also investigate changes in brain structure, and muscle activity associated with handgrip.


Description:

Participants will be randomized to either a no treatment group or one of two low intensity 6-week exercise training. Outcomes will be measured at baseline, post-intervention and 4 weeks post intervention.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date September 2020
Est. primary completion date September 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria:

- Female aged 40-75 yrs

- Right handed, as determined by the Edinburgh Inventory (Oldfield, 1971)

- Proficient in English

- Must be available for the familiarization, and testing sessions

Exclusion Criteria:

- Symptoms for mild or severe depression as determined by a Patient Health Questionnaire (PHQ-8) score >14

- Significant cognitive impairments as defined by a score <28 in the Folstein Mini-Mental Screening Examination (MMSE, Folstein et al .1975).

- Participated in any type of motor imagery or strength training program in the last 5 years, or plan to start any motor imagery or physical strength training program for the 3 months duration of the study

- Neurological, psychiatric, musculoskeletal or other types of disorder that may affect participants sensorimotor function and cognitive abilities

- Current medication believed to affect cognitive/psychomotor function (i.e., opioid, analgesics, anxiolytics or antidepressants)

- History of alcohol, smoking, and drug abuse

- Any contraindication for MRI

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Low Intensity Exercise Training 1
Subjects will perform handgrip exercise training at low intensity (20% maximal force) 5 times a week for 6 weeks (more details not provided to keep study blinded)
Low Intensity Exercise Training 2
Subjects will perform a different handgrip exercise training at low intensity (20% maximal force) 5 times a week for 6 weeks (more details not provided to keep study blinded)

Locations

Country Name City State
United States Kessler Foundation West Orange New Jersey
United States Kessler Institute for Rehabilitation West Orange New Jersey

Sponsors (3)

Lead Sponsor Collaborator
Kessler Foundation Kessler Institute for Rehabilitation, National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hand grip force Primary outcome will be used to compare pre to post change in maximum force contraction at the end of the 6-week intervention between groups.Similar comparison will be done between retention test (4 weeks after training) and posttest (immediately after training). Pretest (before training), Posttest (immediately after end of training), Retention test (4 weeks after end of training)
Secondary Pre to Post changes of functional brain to muscle coupling at maximum handgrip contraction Functional brain to muscle coupling will be measured by computing the EMG-EEG coherence before training, after training, and 4 weeks after end of intervention. Values will be compared between groups. Pretest (before training), Posttest (immediately after end of training), Retention test (4 weeks after end of training)
Secondary Pre to Post changes in EMG amplitude at maximum handgrip contraction EMG of the right arm muscles will be assessed during maximum handgrip contraction before training, after training, and 4 weeks after end of intervention. Values will be compared between groups. Pretest (before training), Posttest (immediately after end of training), Retention test (4 weeks after end of training)
Secondary Pre to Post changes in Brain activity during maximum handgrip contraction functional magnetic resonance imaging will used to measure brain activity when subject performs maximum muscle handgrip contraction before training, after training. Values will be compared between groups. Pretest (before training), Posttest (immediately after end of training)
Secondary Functional brain to muscle (EEG-EMG) phase coupling at low intensity handgrip muscle contraction. Corticomuscular coherence between EEG signal from contralateral motor region and EMG signal from handgrip muscles will be computed while subjects perform handgrip contraction at 20% of their maximum force.Group x Time interaction will be measured. Pretest (before training), Posttest (immediately after end of training), Retention test (4 weeks after end of training)
Secondary EEG Brain connectivity during low intensity handgrip muscle contraction functional connectivity within the brain networks will be studied while subjects perform 20% of their maximum handgrip contraction. Group x Time interaction will be measured. Pretest (before training), Posttest (immediately after end of training)
Secondary Fatigue sustained handgrip contraction task duration Subjects will perform a sustained handgrip contraction task at 20% maximal force.The task duration (a measure of endurance) will be measured for each subject in the three groups, before and after training, and after 4 weeks of end of intervention. Group x Time interaction will be measured. Pretest (before training), Posttest (immediately after end of training), Retention test (4 weeks after end of training)
Secondary functional brain to muscle coupling during fatigue EMG-EEG coherence will be studied when subjects get fatigue after performing a sustained muscle contraction task at 20% maximal force. Group x Time interaction will be measured. Pretest (before training), Posttest (immediately after end of training), Retention test (4 weeks after end of training)
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2